Provided by Tiger Trade Technology Pte. Ltd.

Addex Therapeutics Ltd

7.00
+0.17002.49%
Volume:845.00
Turnover:5.84K
Market Cap:8.86M
PE:-0.77
High:7.00
Open:6.81
Low:6.81
Close:6.83
52wk High:12.05
52wk Low:5.41
Shares:1.27M
Float Shares:1.07M
Volume Ratio:0.40
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.1500
EPS(LYR):-8.9287
ROE:-87.53%
ROA:-15.90%
PB:1.17
PE(LYR):-0.78

Loading ...

Addex Closes 2025 With CHF 6.7M Net Loss And CHF 1.6M Cash, Regains ADX71149 Rights And Invests In Stalicla

Benzinga
·
Apr 30

Press Release: Addex Reports Full Year 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Apr 30

Addex Therapeutics announces GABAB PAM candidate data

TIPRANKS
·
Apr 29

Press Release: Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model

Dow Jones
·
Apr 29

Addex Therapeutics says spin-out company to complete NTX-253 study in Q2

TIPRANKS
·
Apr 23

Press Release: Addex Spin-Out Company Neurosterix on Track to Complete Phase 1 Clinical Study of NTX-253 for Schizophrenia in Q2 2026

Dow Jones
·
Apr 23

Press Release: Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model

Dow Jones
·
Apr 21

Addex Therapeutics Ltd – ADR trading resumes

TIPRANKS
·
Mar 19

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:56 AM

Reuters
·
Mar 18

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:58 AM

Reuters
·
Mar 11

Addex publishes negative allosteric modulators data in Molecular Psychiatry

TIPRANKS
·
Feb 03

Press Release: Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Treatment

Dow Jones
·
Feb 03

Addex Therapeutics Ltd – ADR trading resumes

TIPRANKS
·
Jan 14

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:15 PM

Reuters
·
Jan 14

Addex Therapeutics files to sell $150M in ordinary shares

TIPRANKS
·
Nov 20, 2025